DEVELOPMENT AND EVALUATION OF AN INFORMATION BULLETIN FROM THE NATIONAL DRUG INFORMATION CENTER OF COSTA RICA FOR HEALTH PROFESSIONALS AND STUDENTS
DOI:
https://doi.org/10.15517/0psx0913Abstract
Objective: To develop a bulletin from the National Drug Information Center (CIMED®) of Costa Rica that complies with the accreditation standards of the International Society of Drug Bulletins, thereby enhancing access to reliable updated health-related information for healthcare professionals and students in Costa Rica. Method: The bulletin was desing based on a needs assessment conducted through surveys, along with benchmarking analysis of bulletins accredited by the International Society of Drug Bulletins. Results: Two initial editions were designed on topics of interest—Parkinson’s disease and oncology patients—and published in the Kérwá repository of the University of Costa Rica. The evaluation revealed high levels acceptance regarding design, content, and format. Conclusion: The bulletin represents a key tool for strengthening academic training, clinical practice, and scientific dissemination, consolidating CIMED® as a reference center in pharmaceutical and health information.
Downloads
References
1. Gamboa-Peñaranda C, Zamora-Ilarionov A, Galán-Rodas E. Acceso a información médica actualizada en Internet: retos de la medicina actual. Acta méd costarric. 2014; 56(4): 186-187. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S0001-60022014000400011&lng=en. Consultado: 15 de enero 2025.
2. Jardines Méndez JB. Acceso a la información y equidad en salud. Rev Cubana Salud Pública. 2007; 33(3): 1-8. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662007000300009&lng=es Consultado: 15 de enero 2025.
3. Pellegrini Filho A. Inequidades de acceso a la información e inequidades en salud. Rev Panam Salud Publica. 2002; 11(5/6): 409-412. Disponible en: https://www.scielosp.org/pdf/rpsp/v11n5-6/10725.pdf Consultado: 15 de enero 2025.
4. Zanatta ET, Wanderley GP de M, Branco IK, Pereira D, Kato LH, Maluf EMCP. Fake news: the impact of the internet on population health. Rev Assoc Med Bras. 2021; 67(7):926–930. Consultado: 15 de enero 2025.
5. Escolà-Gascón Á, Dagnall N, Denovan A, Drinkwater K, Diez-Bosch M. Who falls for fake news? Psychological and clinical profiling evidence of fake news consumers. Pers Individ Dif. 2023;200:111893. doi:10.1016/j.paid.2022.111893 Consultado: 10 de julio 2025.
6. Tsirintani M. Fake News and Disinformation in Health Care- Challenges and Technology Tools. Public Health and Informatics: Proceedings of MIE 2021. 2021; 318–321. Disponible en: https://ebooks.iospress.nl/doi/10.3233/SHTI210172 Consultado: 07 de abril 2025.
7. Aïmeur E, Amri S, Brassard G. Fake news, disinformation and misinformation in social media: a review. Social Network Analysis and Mining 2023 13:1. 2023; 13(1):1–36. Disponible en: https://link.springer.com/article/10.1007/s13278-023-01028-5 Consultado: 07 de abril 2025.
8. Wiedenmayer K. Developing Pharmacy Practice. A Focus on Patient Care. The Hague, the Netherlands: World Health Organization and International Pharmaceutical Federation, 2006. Consultado: 07 de abril 2025.
9. Brincat A, Azzopardi LM, Zarb Adami M, Serracino-Inglott A. Development and evaluation of a Drug Information Bulletin. Journal of Pharmaceutical Health Services Research. 2014;5(2):81-88. Consultado: 07 de abril 2025.
10. About the International Society of Drug Bulletins (ISDB) – ISDB – International Society of Drug Bulletins. Disponible en: https://isdbweb.org/what-is-isdb Consultado: 11 de febrero 2025.
11. Pintor R, Carrasco J.M, Barnés M.T, García Marco D, De Juana P, Bermejo T. Impacto de un boletín informativo sobre interacciones en la prescripción médica. 1996; 20(4):238-244. Consultado: 20 de enero 2025.
12. Ngenzi JL, Scott RE, Mars M. Information and communication technology to enhance continuing professional development (CPD) and continuing medical education (CME) for Rwanda: a scoping review of reviews. BMC Medical Education. 2021;21(1):1–8. Disponible en: https://bmcmededuc.biomedcentral.com/articles/10.1186/s12909-021-02607-w Consultado: 06 de mayo 2025.
13. Yadeta TA, Mohammed A, Alemu A, Behir K, Balis B, Letta S. Utilization of continuous professional development among health professionals in East Ethiopia: a multi-health facility-based cross-sectional study. BMC Medical Education. 2024;24(1):1–9. Disponible en: https://bmcmededuc.biomedcentral.com/articles/10.1186/s12909-024-05036-7 Consultado: 06 de mayo 2025.
14. Lankford W. Benchmarking: Understanding the Basics. The Coastal Business Journal. 2022;1(1). Disponible en: https://digitalcommons.coastal.edu/cbj/vol1/iss1/8 Consultado: 03 de abril 2025.
15. Alderman CP, Monsanto HA, Dion P. Development and Evaluation of an Electronic Drug and Therapeutics Bulletin. 2002; 36(10):1637–1641. Disponible en: https://journals.sagepub.com/doi/10.1345/aph.1A330?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed Consultado: 17 de febrero 2025.
16. Blanco P. Costa Rica se sitúa entre los países con mayor apertura a la información científica. Universidad de Costa Rica. Disponible en: https://www.ucr.ac.cr/noticias/2022/6/20/costa-rica-se-situa-entre-los-paises-con-mayor-apertura-a-la-informacion-cientifica.html Consultado: 28 de mayo 2025.
17. Laera E, Gutzman K, Spencer A, Beyer C, Bolore S, Gallagher J, et al. Why are they not accessing it? User barriers to clinical information access. Journal of the Medical Library Association. 2021;109(1):126-132. Disponible en: https://jmla.pitt.edu/ojs/jmla/article/view/1051/1242 Consultado: 01 de junio 2025.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Roberto Tovar-Arrieta, Victoria Hall-Ramírez, Dr. Alfonso Pereira-Céspedes, Milania Rocha-Palma (Autor/a)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licencias de la Revista
La Revista utiliza las licencias de CreativeCommons (CC) para proteger sus derechos de autor y para garantizar el acceso libre y abierto, específicamente la CC-BY-NC.
Reconocimiento-NoComercial 4.0
CC BY-NC
Esta licencia permite a otros entremezclar, ajustar y construir a partir de su obra con fines no comerciales, y aunque en sus nuevas creaciones deban reconocerle su autoría y no puedan ser utilizadas de manera comercial, no tienen que estar bajo una licencia con los mismos términos.
